The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 28, 2021
Filed:
Jun. 30, 2017
Applicants:
Nant Holdings Ip, Llc, Culver City, CA (US);
Nantcell, Inc., Culver City, CA (US);
Inventors:
Patrick Soon-Shiong, Culver City, CA (US);
Kayvan Niazi, Culver City, CA (US);
Shahrooz Rabizadeh, Culver City, CA (US);
Hans G. Klingemann, Culver City, CA (US);
Laurent H. Boissel, Culver City, CA (US);
Barry J. Simon, Culver City, CA (US);
Assignees:
NantCell Inc., Culver City, CA (US);
Nant Holdings IP LLC, Culver City, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/20 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001106 (2018.08); A61K 38/2013 (2013.01); A61K 38/2046 (2013.01); A61K 38/2086 (2013.01); A61K 39/00117 (2018.08); A61K 39/001152 (2018.08); A61K 39/001164 (2018.08); A61K 39/001182 (2018.08); C07K 16/2827 (2013.01); A61K 2039/507 (2013.01); A61K 2039/523 (2013.01); C07K 2317/76 (2013.01);
Abstract
Cancer is treated using coordinated treatment regimens that uses various compounds and compositions that drive a tumor from the escape phase of cancer immunoediting to the elimination and equilibrium phase of cancer immunoediting.